Evrima Technologies Pty Ltd

12:00 PM - 1:00 PM (PDT), Tuesday, June 14, 2022
Bringing new medicines to market is expensive and time consuming. Patient recruitment and site management drive costs and delays. Founded in 2019, Evrima seeks to solve these bottlenecks, and is disrupting the clinical trial market by developing techniques and technology that enable seamless and efficient trial execution.
The company partners with pharmaceutical, biotech and medical device companies to provide sponsors and CROs patient recruitment, enrollment and retention services through a cloud-based platform that automates the patient recruitment process and provides distributed trial management.
With over 60,000 patients, and 100+ sites across Australia and New Zealand, Evrima's technology is used to find, match, enrol and retain dozens of research participants in relevant trials every day. Evrima has successfully recruited participants for early and late phase trials across a variety of therapeutic areas including neurology, gastroenterology, dermatology, women’s health, vaccine development and rare diseases.
To date, we have relied on our reputation and network in Australia to drive our sales pipeline. In 2022, our growth strategy includes positioning our company to clinical-stage life sciences and medical device companies, such that we can increase our brand awareness and sales prospects earlier in the sales cycle, as well as launch into new markets.
Speaker
photo
CEO & Founder
Evrima Technologies Pty Ltd